Flot.bio reposted this
In 2000, Harpreet co-founded a venture after his PhD. Now, Immatics is one of the 15 most valuable European biotechs. Great to meet him in person for the first time and to record an episode while I was in Munich 🇩🇪 We talked about the field of PRAME receptors, TCR therapeutics and Cell Therapy at large. We also spoke about the combination with mRNA therapeutics and his upbringing in a Sikh family in Germany. Full episode will be online first week of September ⏰
If you haven't seen it already, the post is now live! https://flot.bio/episode/harpreet-singh-immatics/
Thank you, Philip, for inviting me to be a guest on your podcast. It was a pleasure to sit down with you at the Immatics office in Munich and discuss such a wide range of topics, from our scientific work on targets and TCRs to leveraging our TCR-based immunotherapies to make a meaningful impact on the lives of cancer patients...and more. I'm looking forward to seeing the full episode!
Founder & CEO @ Flot.bio
2moThanks to Joanne Tudorica for taking this nice picture and helping make this happen, Helen Albert for the previous interview, and Ingmar Hoerr for the reintro 🙏😇